Related references
Note: Only part of the references are listed.FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
Ji Woong Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Reconstitution of circulating lymphocyte counts in FTY720-treated MS patients
Trina A. Johnson et al.
CLINICAL IMMUNOLOGY (2010)
FTY720 Ameliorates MOG-Induced Experimental Autoimmune Encephalomyelitis by Suppressing Both Cellular and Humoral Immune Responses
Dimitrios Papadopoulos et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
Robert C. Axtell et al.
NATURE MEDICINE (2010)
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
M. Mehling et al.
NEUROLOGY (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Jeffrey A. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid Receptor Nomenclature
Jerold Chun et al.
PHARMACOLOGICAL REVIEWS (2010)
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
Volker Brinkmann
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors
Florian Mullershausen et al.
NATURE CHEMICAL BIOLOGY (2009)
Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules
David Marsolais et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Incomplete Inhibition of Sphingosine 1-Phosphate Lyase Modulates Immune System Function yet Prevents Early Lethality and Non-Lymphoid Lesions
Peter Vogel et al.
PLOS ONE (2009)
Treatment with Immunosuppressants FTY720 and Tacrolimus Promotes Functional Recovery after Spinal Cord Injury in Rats
Jie Zhang et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod
Veronique E. Miron et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
FTY720 modulates human oligodendrocyte progenitor process extension and survival
Veronique E. Miron et al.
ANNALS OF NEUROLOGY (2008)
Astrocytes in multiple sclerosis: A product of their environment
A. Nair et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease
Yun-Ping Wu et al.
HUMAN MOLECULAR GENETICS (2008)
Neuroprotection and neuroregeneration in multiple sclerosis
Martin Stangel
JOURNAL OF NEUROLOGY (2008)
Central nervous system-directed effects of FTY720 (fingolimod)
Veronique E. Miron et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
M. Mehling et al.
NEUROLOGY (2008)
Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis
Kumlesh K. Dev et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells
C. G. Jung et al.
GLIA (2007)
Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: Consequences for mode of action in multiple sclerosis
Carolyn A. Foster et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors
Rochelle P. Coelho et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis
Balazs Balatoni et al.
BRAIN RESEARCH BULLETIN (2007)
Astrocytes - Friends or foes in multiple sclerosis
Anna Williams et al.
GLIA (2007)
Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors
Florian Mullershausen et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Sphingosine-1-phosphate/sphingosine kinase pathway is involved in mouse airway hyperresponsiveness
Fiorentina Roviezzo et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration
Alexander S. Novgorodov et al.
FASEB JOURNAL (2007)
Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons
Taketoshi Kajimoto et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS
D. H. Miller et al.
NEUROLOGY (2007)
Sphingosine 1-phosphate regulates inflammation-related genes in human endothelial cells through S1P1 and S1P3
Chi-Iou Lin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubipuitinylation and proteasomal degradation of the receptor
Myat Lin Oo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Oral-intravenous crossover study of fingolimod pharmacokinetics, lymphocyte responses and cardiac effects
John M. Kovarik et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2007)
Sphingosine 1-phosphate causes airway hyper-reactivity by Rho-mediated myosin phosphatase inactivation
Hiroaki Kume et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Essential roles of sphingosine 1-phosphate/S1P(1) receptor axis in the migration of neural stem cells toward a site of spinal cord injury
Atsushi Kimura et al.
STEM CELLS (2007)
FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury
Zhiyuan Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Sphingosine-1-phosphate signaling in the cardiovascular system
Stephan L. M. Peters et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Randomized controlled trial of FTY720 versus MMF in de novo renal transplantation
Helio Tedesco-Silva et al.
TRANSPLANTATION (2006)
FTY720 preferentially depletes naive T cells from peripheral and lymphoid organs
Matthias Hofmann et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
FTY720 versus MMF with cyclosporine in de novo renal transplantation:: A 1-year, randomized controlled trial in Europe and Australasia
M. Salvadori et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Remyelination is extensive in a subset of multiple sclerosis patients
Peter Patrikios et al.
BRAIN (2006)
Plasma cell S1P1 expression determines secondary lymphoid organ retention versus bone marrow tropism
Kenji Kabashima et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Oral fingolimod (FTY720) for relapsing multiple sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Physiologically based pharmacokinetic modeling of FTY720 (2-amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in rats after oral and intravenous doses
Guy M. L. Meno-Tetang et al.
DRUG METABOLISM AND DISPOSITION (2006)
FTY720: Placebo-controlled study of the effect on cardiac rate and rhythm in healthy subjects
Robert Schmouder et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors
R Bassi et al.
GLIA (2006)
Medical progress: Multiple sclerosis - The plaque and its pathogenesis
EM Frohman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720
B Zemann et al.
BLOOD (2006)
Pulmonary and vascular pharmacology of sphingosine 1-phosphate
Volker Brinkmann et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes
II Singer et al.
JOURNAL OF IMMUNOLOGY (2005)
Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors
HS Saini et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Essential role for sphingosine kinases in neural and vascular development
K Mizugishi et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720
Y Kharel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
FTY720, a novel immunomodulator in de novo kidney transplant patients: Pharmacokinetics and exposure-response relationship
A Skerjanec et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients
SR Schwab et al.
SCIENCE (2005)
Sphingosine 1-phosphate and its receptors: An autocrine and paracrine network
H Rosen et al.
NATURE REVIEWS IMMUNOLOGY (2005)
FTY720, a novel immunomodulator:: Efficacy and safety results from the first phase 2A study in de novo renal transplantation
H Tedesco-Silva et al.
TRANSPLANTATION (2005)
Activation of the SPHK/SIP signalling pathway is coupled to muscarinic receptor-dependent regulation of peripheral airways -: art. no. 48
M Pfaff et al.
RESPIRATORY RESEARCH (2005)
Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients
SI Park et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2005)
Immunomodulator FTY720 induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3
M Tölle et al.
CIRCULATION RESEARCH (2005)
The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel IKACh
L Koyrakh et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Extracellular release of newly synthesized sphingosine-1-phosphate by cerebellar granule cells and astrocytes
V Anelli et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Edg8/S1P5: An oligodendroglial receptor with dual function on process retraction and cell survival
C Jaillard et al.
JOURNAL OF NEUROSCIENCE (2005)
Rate of brain atrophy in relapsing MS decreases during treatment with IFNβ-1a
M Hardmeier et al.
NEUROLOGY (2005)
Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit
CG Lo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Single-dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects
JM Kovarik et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Multiple-dose FTY720: Tolerability, pharmacokinetics, and lymphocyte responses in healthy subjects
JM Kovarik et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes
M Forrest et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate
MG Sanna et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
FTY720 exerts differential effects on CD4+ and CD8+ T-lymphocyte subpopulations expressing chemokine and adhesion receptors
T Böhler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Sphingosine-1-phosphate induces proliferation and morphological changes of neural progenitor cells
J Harada et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
M Matloubian et al.
NATURE (2004)
Endothelial cell barrier regulation by sphingosine 1-phosphate
BJ McVerry et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice
M Webb et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720
ML Allende et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
FTY720: Sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function
V Brinkmann et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
FTY720, a novel immunomodulator:: Efficacy and safety results from the first phase 2A study in de novo renal transplantation
H Tedesco-Silva et al.
TRANSPLANTATION (2004)
Central memory and effector memory T cell subsets: Function, generation, and maintenance
F Sallusto et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Lysophospholipid receptors: Signaling and biology
I Ishii et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
Constitutive expression of the SlP(1) receptor in adult tissues
SS Chae et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2004)
Growth factor pre-treatment differentially regulates phosphoinositide turnover downstream of lysophospholipid receptor and metabotropic glutamate receptors in cultured rat cerebrocortical astrocytes
TS Rao et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2004)
Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes
NC Yu et al.
GLIA (2004)
Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases
A Billich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Pharmacological characterization of lysophospholipid receptor signal transduction pathways in rat cerebrocortical astrocytes
TS Rao et al.
BRAIN RESEARCH (2003)
The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2
SW Paugh et al.
FEBS LETTERS (2003)
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: A multicenter, randomized, placebo-controlled, phase I study
BD Kahan et al.
TRANSPLANTATION (2003)
Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients
K Budde et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate
S Salomone et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
The roles of ceramide and complex sphingolipids in neuronal cell function
R Buccoliero et al.
PHARMACOLOGICAL RESEARCH (2003)
Sphingosine-1-phosphate: An enigmatic signalling lipid
S Spiegel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Signaling and biological actions of sphingosine 1-phosphate
T Hla
PHARMACOLOGICAL RESEARCH (2003)
Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells
JH Xie et al.
JOURNAL OF IMMUNOLOGY (2003)
Assessment of the role of sphingosine 1-phosphate and its receptors in high-density lipoprotein-induced stimulation of astroglial cell function
E Malchinkhuu et al.
BIOCHEMICAL JOURNAL (2003)
Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes
SD Sorensen et al.
MOLECULAR PHARMACOLOGY (2003)
Edg-8 receptors are preferentially expressed in oligodendrocyte lineage cells of the rat CNS
K Terai et al.
NEUROSCIENCE (2003)
Linking Chinese medicine and G-protein-coupled receptors
DS Im
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells
M Graeler et al.
FASEB JOURNAL (2002)
Embryonic brain expression analysis of lysophospholipid receptor genes suggests roles for s1p1 in neurogenesis and s1p1-3 in angiogenesis
C McGiffert et al.
FEBS LETTERS (2002)
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
V Brinkmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cell type-specific localization of human cardiac S1P receptors
D Mazurais et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2002)
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
S Mandala et al.
SCIENCE (2002)
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis
A Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Nerve growth factor survival signaling in cultured hippocampal neurons is mediated through TRKA and requires the common neurotrophin receptor p75
C Culmsee et al.
NEUROSCIENCE (2002)
Antiproliferative properties of sphingosine-1-phosphate in human hepatic myofibroblasts
A Pébay et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Basic fibroblast growth factor-induced proliferation of primary astrocytes - Evidence for the involvement of sphingomyelin biosynthesis
L Riboni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma:: a possible role in regulating cardiac function via sphingolipid receptors
K Liliom et al.
BIOCHEMICAL JOURNAL (2001)
FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression
V Brinkmann et al.
TRANSPLANTATION PROCEEDINGS (2001)
Lysophospholipid receptors
N Fukushima et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)
Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation
YJ Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Cultured granule cells and astrocytes from cerebellum differ in metabolizing sphingosine
L Riboni et al.
JOURNAL OF NEUROCHEMISTRY (2000)
FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory
DD Pinschewer et al.
JOURNAL OF IMMUNOLOGY (2000)
Characterization of a novel sphingosine 1-phosphate receptor, Edg-8
DS Im et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
